AMRA Medical AB

Company profile

About AMRA Medical AB

AMRA Medical AB is a global leader in health informatics, pioneering advanced fat and muscle analysis using proprietary MRI-based technologies. The company's gold-standard platform delivers precise biomarkers that provide a deeper understanding of metabolic and musculoskeletal health, supporting data-driven decision-making in both research and clinical care. Founded from academic research, AMRA has developed a patented, automated method for classifying and quantifying fat and muscle groups with unprecedented accuracy and precision. The company's technology analyzes MRI scans to measure over 55,000 fat and muscle parameters, going far beyond traditional anthropometric measures, BIA, DXA, or single-slice assessments. AMRA's platform is scanner-agnostic, working across major 1.5T and 3T MR scanners to deliver standardized, reproducible results. AMRA serves two primary markets: research services for pharmaceutical companies and clinical trials (AMRA® Researcher platform with imaging and insights biomarkers), and clinical services for healthcare providers (AMRA® BCP Scan for body composition profiling and AMRA® MAsS Scan for muscle quality assessment). The company's technology enables detailed body composition analysis including subcutaneous, visceral, and ectopic fat compartments, individual muscle group volumes, and diffuse fat infiltration measurements. With over 500 certified imaging sites globally, 200+ scientific publications, and a reference dataset of 55,000+ measurements, AMRA supports researchers in drug development—particularly for metabolic diseases, obesity, diabetes, and musculoskeletal conditions—and clinicians in preventative health and personalized patient care. The company's standardized, cloud-based workflows minimize setup complexity while delivering robust biomarkers that impact clinical trial outcomes and patient lives.

Company description · AMRA Medical AB official website